![Mark Lotter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lotter
Vorstandsvorsitzender bei
Nuance Pharma (Shanghai) Co., Ltd.
Profil
Mark Gavin Lotter was the founder of NovaMed Pharmaceuticals, Inc., founded in 2005, where the title held was President & Chief Executive Officer from 2006 to 2010.
Mr. Lotter is the founder of Nuance Pharma (Shanghai) Co., Ltd., founded in 2014, holding the title of Chief Executive Officer since 2014.
Former jobs include Director & CEO-China Operations at SciClone Pharmaceuticals LLC in 2012, Chief Executive Officer at Aspen Pharmacare Holdings Ltd., Independent Non-Executive Director at China Health Group, Inc. from 2015 to 2019, and Vice President-Operations at AstraZeneca Pharmaceuticals LP.
Education history includes undergraduate studies at the University of Natal and an MBA from the University of South Africa.
Aktive Positionen von Mark Lotter
| Unternehmen | Position | Beginn |
|---|---|---|
Nuance Pharma (Shanghai) Co., Ltd.
 Nuance Pharma (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Vorstandsvorsitzender | 12.08.2014 |
Ehemalige bekannte Positionen von Mark Lotter
| Unternehmen | Position | Ende |
|---|---|---|
| CHINA HEALTH GROUP INC. | Direktor/Vorstandsmitglied | 20.06.2019 |
| SCICLONE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 14.12.2012 |
NovaMed Pharmaceuticals, Inc.
 NovaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Gründer | 18.04.2011 |
| ASPEN PHARMACARE HOLDINGS LIMITED | Vorstandsvorsitzender | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Geschäftsführer | - |
Ausbildung von Mark Lotter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
China Health Group, Inc.
 China Health Group, Inc. Pharmaceuticals: OtherHealth Technology Provides drug discovery and development services | Health Technology |
Aspen Pharmacare Holdings Ltd.
 Aspen Pharmacare Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals products | Health Technology |
University of Natal
 University of Natal Other Consumer ServicesConsumer Services College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
University of South Africa
 University of South Africa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovaMed Pharmaceuticals, Inc.
NovaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Nuance Pharma (Shanghai) Co., Ltd.
Nuance Pharma (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
